An Italian hospital has injected a first volunteer with an anti-COVID-19 vaccine as part of human trials expected to last six months.

The woman, in her 50s, received the first dose developed by Rome-based biotech company ReiThera at the capital’s Spallanzani Institute for infectious diseases.

The trials, developed between ReiThera and Spallanzani researchers, will be carried out on 90 volunteers divided into groups by age to test the efficacy of different dosages of the vaccine, developed since March.

Aljazeera

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.